Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urine

https://doi.org/10.1016/0731-7085(92)80085-2Get rights and content

Abstract

Assay procedures for analysis of entacapone, (E)-2-cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)-propenamide, and its Z-isomer in human plasma and urine are described. The methods were based on reversed-phase liquid chromatography with amperometric detection. Entacapone and its Z-isomer were extracted with n-hexane-ethyl acetate mixtures after acidification with hydrochloric acid. From urine extracts the analytes were back-extracted into phosphate buffer (pH 7.2). During sample treatment 1–2% of entacapone was changed to the Z-isomer. With recoveries exceeding 75% the relative standard deviations for within-day precision were less than 11% for plasma and less than 6% for urine at the quantitation limit (10 ng ml−1) and less than 6% for both methods at higher concentrations (20–2000 ng ml−1). The assays were specific with respect to all known metabolites and selective, sensitive and precise enough for determination of entacapone and its Z-isomer in plasma and urine down to 10 ng ml−1. The methods are thus suitable for the kind of pharmacokinetic studies exemplified in this paper.

References (13)

  • P.T. Männistö et al.

    Trends Pharmacol. Sci.

    (1989)
  • T. Wikberg et al.

    J. Pharm. Biomed. Anal.

    (1991)
  • H.C. Guldberg et al.

    Pharm. Rev.

    (1975)
  • J.G. Nutt et al.

    Clin. Neuropharmacol.

    (1984)
  • J.M. Cedarbaum

    Clin. Pharmacokinet.

    (1987)
  • R.J. Hardie et al.

    Br. J. Clin. Pharmacol.

    (1986)
There are more references available in the full text version of this article.

Cited by (46)

  • A novel electrochemical nanosensor based on NH <inf>2</inf> -functionalized multi walled carbon nanotubes for the determination of catechol-orto-methyltransferase inhibitor entacapone

    2019, Journal of Pharmaceutical and Biomedical Analysis
    Citation Excerpt :

    Moreover, mean maximum plasma concentrations (Cmax) of 650–1559 ng.mL−1 (2.13 × 10−6 – 5.11 × 10−6 mol.L−1) are generally reached at (tmax) of 0.70–1.82 h. The elimination of Entacapone is biphasic, with an elimination half-life of 1–2 h [4,5]. The mechanism of action of ENP is believed to occur through its ability of inhibiting COMT and altering the plasma pharmacokinetics of levodopa making it thus bioavailable for prolong therapeutic effect [6,7].

  • Bioanalytical chromatographic methods for the determination of catechol-O-methyltransferase inhibitors in rodents and human samples: A review

    2012, Analytica Chimica Acta
    Citation Excerpt :

    The extent to which interconversion, epimerization or E to Z isomerization are minimized depends on experimental conditions during the bioanalytical procedure; interconversion depends on the temperature and pH, whereas epimerization and E to Z isomerization are influenced by pH or light exposure [52]. Thus, in the analysis of COMT inhibitors care must be taken during sample handling and preparation, especially when working with entacapone, because it can isomerize to (Z)-entacapone; this reaction seems to be catalyzed by daylight and plasma proteins, so that sample handling must be rapid and protected from daylight [31,46]. As listed in Table 3, some urine samples have only been diluted to determine tolcapone and some of its metabolites [30,35].

  • Development of characterization methods for entacapone in a pharmaceutical bulk

    2011, Journal of Pharmaceutical and Biomedical Analysis
View all citing articles on Scopus
View full text